OTHER CYCLERION sGC STIMULATORS
Return to Archive
Olinciguat had dose-proportional pharmacokinetics at steady state in a Phase 1 multiple-ascending dose study in healthy volunteers
Healthy volunteers received 7 days of once-daily olinciguat at doses of 1-, 2- or 5-mg. The graph presents mean plasma concentrations of olinciguat over 24 hours on day 7.
Mittleman et al. Blood 2017, 130 (Suppl 1) 3533.